P2‐168: Screening for Serum Biomarkers for Cerebral Amyloid Angiopathy and Alzheimer Disease: Results from a Discovery Assay of 65 Cytokines | Zendy

Hegedus Janka | Zendy; Alvarez-Veronesi Ana | Zendy; Zwiers Angela | Zendy; Charlton Anna | Zendy; Sekhon Ramnik | Zendy; Smith Eric E. | Zendy

Premium

P2‐168: Screening for Serum Biomarkers for Cerebral Amyloid Angiopathy and Alzheimer Disease: Results from a Discovery Assay of 65 Cytokines

Author(s) -

Hegedus Janka,

Alvarez-Veronesi Ana,

Zwiers Angela,

Charlton Anna,

Sekhon Ramnik,

Smith Eric E.

Publication year - 2016

Publication title -

alzheimer's and dementia

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 6.713

H-Index - 118

eISSN - 1552-5279

pISSN - 1552-5260

DOI - 10.1016/j.jalz.2016.06.1335

Subject(s) - eotaxin , cerebral amyloid angiopathy , medicine , cerebrospinal fluid , immunology , inflammation , microglia , pathology , chemokine , dementia , disease

Amsterdam, Netherlands; Bioethics Unit, IRCCS Centro San Giovanni di Dio, Brescia, Italy; 16 Mayo Clinic, Rochester, MN, USA; 17 Karolinska Institutet, Center for Alzheimer Research, Div. of Neurogeriatrics,, Huddinge, Sweden; IRCCS Instituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy; Memory Clinic and LANVIE Laboratory of Neuroimaging of Aging, University Hospitals and University of Geneva, Geneva, Switzerland. Contact e-mail: mboccardifbf@googlemail.com

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research